Viral Hepatitis
Copyright ©The Author(s) 2003. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 15, 2003; 9(7): 1516-1520
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1516
A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis
Xu Yang, Xiao-Peng Tang, Jian-Hua Lei, Hong-Yu Luo, Yong-Hong Zhang
Xu Yang, Xiao-Peng Tang, Jian-Hua Lei, Hong-Yu Luo, Yong-Hong Zhang, Liver Disease Research Center, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr Xu Yang, Liver Disease Research Center, The Second Xiangya Hospital, Central South University, 86 Ren Min Avenue, Changsha 410011, Hunan Province, China yangxu@vip.163.com
Telephone: +86-731-5524222-2263 Fax: +86-731-5533525
Received: March 4, 2003
Revised: March 24, 2003
Accepted: April 1, 2003
Published online: July 15, 2003
Abstract

AIM: HBsAg is the most important serological marker for acute or chronic hepatitis B. Nevertheless, there were reports of HBsAg-negative infection caused by hepatitis B virus in recent years. We had a patient with crytogenic cirrhosis who was negative for HBsAg, positive for anti-HBs and HBeAg. This paper was to explore the pathogenic and molecular basis of the unusual serological pattern.

METHODS: HBV serologic markers were qualitatively and quantitatively determined. HBV DNA in serum was qualitatively tested using routine Polymerase chain reaction(PCR), and the viral level was determined with real-time fluorescence quantitative PCR. HBsAg gene was amplified and cloned. Four clones were sequenced. The new genomic sequences were compared with GenBank on the DNA level as well as the protein level.

RESULTS: The qualitative results of serological markers were HBsAg(-), anti-HBs(+), HBeAg(+), anti-HBe(-) and anti-HBc(+). The quantitative results of serological marker were HBsAg (S/N): 0.77 (cut off of S/N: ≥ 2.00), HBeAg (S/N): 56.43 (cut off S/N: ≥ 2.10), anti-HBc (S/CO): 2.03 (cut off of S/CO: ≤ 1.00). The viral level was as high as 1.54 × 109 copies/ml. Sequencing of the HBsAg gene clones revealed a unique point mutation at nucleotide 336 (C to A), which resulted in a novel stop codon at aa 61. The novel HBsAg gene stop mutation had not been described.

CONCLUSION: The lack of detection of HBsAg in the presence of high viral levels of replication may be caused by the existence of viral genomes harboring point mutations which resulted in stop codon upstream of the “a” determinant in HBsAg gene.

Keywords: $[Keywords]